Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01186718 · ClinicalTrials.gov registry record
Interexaminer Reliability, Outcomes for Manipulation of Cervical Dysfunction, 3-D Kinematics
A clinical trial, sponsored by Michigan State University.
- Completed
- Registry status
- 30
- Enrollment target
NCT01186718: Completed study, sponsored by Michigan State University.
NCT01186718 is a clinical trial that has completed, run by Michigan State University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01186718 has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this project is to quantify 3-dimensional (3-D) cervical motion pattern changes that result from osteopathic manipulation treatment (OMT) in an experimental subject group diagnosed with somatic dysfunction. The kinematic data will include the entire 3-D motion trajectories of the head, resulting in range of motion (ROM) and angular data for the primary and secondary motions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-08 |
What the finished NCT01186718 record still lists
NCT01186718 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01186718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01186718 about?
NCT01186718 is a clinical study titled "Interexaminer Reliability, Outcomes for Manipulation of Cervical Dysfunction, 3-D Kinematics". The purpose of this project is to quantify 3-dimensional (3-D) cervical motion pattern changes that result from osteopathic manipulation treatment (OMT) in an experimental subject group diagnosed with somatic dysfunction. The kinematic data will include the entire 3-D motion trajectories of the head...
What is the current status of trial NCT01186718?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-09. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT01186718?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia